Clinical Trials Using CXCR4 Inhibitor POL6326

Clinical trials are research studies that involve people. The clinical trials on this list are studying CXCR4 Inhibitor POL6326. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trial 1 of 1
  • Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer

    This is a phase 3, multicenter, open-label, randomized active-controlled, parallel group to investigate the efficacy, safety and tolerability of intravenous balixafortide given with eribulin versus eribulin alone in the treatment of HER2 negative, Locally Recurrent or Metastatic Breast Cancer.
    Location: 8 locations